BioAsia 2024: Convergence of Hyderabad’s technology and life sciences, says KTR

HYDERABAD: Unveiling BioAsia 2024, with the theme ‘Data and AI - Redefining Possibilities’, slated for February 26 and 28, IT and Industries Minister KT Rama Rao (KTR) said that it spoke volumes about Hyderabad's unique convergence of technology and life sciences, shaping a new era of healthcare innovation.

He announced the eagerly awaited 21 edition of BioAsia 2024 an extraordinary platform where data and Artificial Intelligence (AI) converge to redefine possibilities across the life sciences and healthcare sectors, in Hyderabad on Saturday

The BioAsia 2024 would explore the pivotal role of data-driven technologies and artificial intelligence in shaping the future of healthcare, pharmaceuticals, and biotechnology. As the world increasingly harnesses the power of digital innovation, the theme aptly underscored the immense potential at the intersection of technology and life sciences.

Speaking about BioAsia 2024, KTR said: "BioAsia has always been a catalyst for transformative ideas and partnerships. The theme of data and AI speaks to Hyderabad's unique convergence of technology and life sciences, shaping a new era of healthcare innovation. This flagship event is a testament to our commitment to fostering collaborations that drive progress and impact on a global scale. With the world's leading minds converging in Hyderabad, we are set to explore the uncharted frontiers of this transformative era."

“Hyderabad is the place where technology meets biology and data sciences meet life sciences," said KTR capturing the essence of the city's prowess in marrying cutting-edge technology with life sciences expertise.

BioAsia consistently rose as a global platform that fostered meaningful dialogues among industry leaders, policymakers, researchers, and innovators. BioAsia 2024 would elevate this legacy by assembling influential global leaders and participants from more than 50 countries, fostering collaborations and partnerships that transcend geographical boundaries.

"In an era marked by breakthroughs in genomics, precision medicine, and digital health, the convergence of data and AI promises to reshape research, diagnostics, treatment, and patient care. This year’s theme encapsulates the profound impact of data-driven technologies and artificial intelligence on the trajectory of healthcare, biotechnology, pharmaceuticals, and medical devices. BioAsia 2024 will unlock new dimensions in the world of life sciences and healthcare through the lens of Data and AI. It's an event not to be missed” said Shakthi M Nagappan, CEO of Telangana Lifesciences and BioAsia, Government of Telangana.

BioAsia 2024 would be a landmark event that would set the stage for meaningful conversations, innovations, and collaborations, driving the life sciences and healthcare sectors to new horizons.

"BioAsia 2024 is the embodiment of our vision to harness the potential of data and AI to redefine healthcare possibilities globally. BioAsia is the perfect platform to explore the synergy between data, AI, and life sciences, propelling us into a future of transformative healthcare" said Jayesh Ranjan, Principal Secretary (I&C), Telangana Government.

“Artificial intelligence and machine learning are exerting a transformative effect on the life sciences industry. Gen AI, the recent buzzword is a new addition to the list of transformative forces. Though at an early stage of adoption, the life sciences industry is likely to find numerous future use cases of these transformative technologies which could be the realm of imagination today. BioAsia 2024’s theme,” said Suresh Subramanian, Partner and National Life Sciences Leader, Ernst & Young LLP.